Why is Zenith Drugs falling/rising?

As of 12-Aug, Zenith Drugs Ltd is experiencing a decline in its stock price, currently at 64.00, which reflects a decrease of 1.0 or 1.54%. The stock has underperformed its sector by 1.92% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown a significant decline in performance over various periods, with a 1-week return of -7.04%, a 1-month return of -8.57%, and a year-to-date return of -20.79%. The delivery volume has also decreased by 3.85% compared to the 5-day average, indicating falling investor participation. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Zenith Drugs' performance has been notably weaker than the benchmark, the Sensex, which has only declined by 0.67% over the past week and has a year-to-date increase of 3.56%. This stark contrast highlights the stock's struggles in comparison to the overall market performance. The significant underperformance against the benchmark and the declining investor interest suggest that the stock is facing challenges that are not aligned with the broader market trends.